"Haik Humble Eye Center is proud to be the only practice in Northeast Louisiana that offers every aspect of eye care to the community. From eye examinations to complex surgical procedures, our members embrace the tradition of teamwork in providing vision care services. Over the past 35 years, above all else, it is our caring for people like you who has assured our sustained growth and expansion of services. Yet one thing hasn’t changed over the years: our commitment to providing the highest quality eye care. Our commitment, then and now is to exceed our patient’s expectation in quality care and service to the patient and family."

During the past decade, Eye Associates of Northeast Louisiana conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 1 clinical trials were completed, i.e. on average, 25% percent of trials that started reached the finish line to date. In the past 5 years, 3 clinical trials started and 1 clinical trials were completed. i.e. 33.3% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eye Associates of Northeast Louisiana" #1 collaborator was "InFocus Clinical Research" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Eye Associates of Northeast Louisiana" are "Diabetic Macular Edema (DME)" (1 trials), "Neovascular Age-Related Macular Degeneration" (1 trials), "Non-proliferative Diabetic Retinopathy" (1 trials), "Proliferative Diabetic Retinopathy" (1 trials) and "Retinal Vein Occlusion" (1 trials). Many other conditions were trialed in "Eye Associates of Northeast Louisiana" in a lesser frequency.

Most popular intervention types in "Eye Associates of Northeast Louisiana" are "Drug" (3 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "ANXV" (1 trials), "Aflibercept" (1 trials), "Drug: GB-102" (1 trials), "ILUVIEN 0.19 MG" (1 trials) and "OPL-0401 Dose 1" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eye Associates of Northeast Louisiana" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Eye Associates of Northeast Louisiana". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 2 completed trials in Eye Associates of Northeast Louisiana, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eye Associates of Northeast Louisiana, 0 "Phase 1" clinical trials were conducted, 3 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".